Literature DB >> 28623398

Endothelial vascular markers in coronary surgery.

Diana M Valencia-Nuñez1,2,3, Willy Kreutler4, Javier Moya-Gonzalez5,6, Pedro Alados-Arboledas5, Ignacio Muñoz-Carvajal5,6, Andrés Carmona6, Rafael Ramirez-Chamond7, Julia Carracedo-Añon8.   

Abstract

Coronary heart disease is associated with high morbidity and mortality. Endothelial dysfunction in affected patients is linked to long-term atherosclerotic disease progression and cardiovascular event rates. The present paper reports on changes in the levels of endothelial progenitor cells (VEGFR2/CD133/CD34), essential for endothelial repair, and of endothelial microvesicles (CD31/annexin V) as indicators of endothelial lesion, in patients undergoing coronary bypass surgery with respect both to baseline levels and to counts in healthy subjects. In an observational descriptive study, 31 patients scheduled for coronary revascularization surgery were compared with those of 25 healthy controls. In a subsequent longitudinal study, patients undergoing surgery were monitored at 5 timepoints up until 48 h after surgery. Endothelial progenitor cell (VEGFR2/CD133/CD34) and endothelial microvesicle (CD31/annexin V) levels were quantified by flow cytometry. Baseline endothelial progenitor cell counts in coronary patients were significantly lower than those of healthy controls (p < 0.001); however, after surgery, levels rose steadily over all 5 timepoints to 48 h  with statistically significant differences (p < 0.001) between intra-operative and 48 h after surgery (T5). Endothelial microvesicle levels were significantly higher in coronary patients prior to surgery than in healthy controls (p < 0.001), and despite declining at 48 h remained significantly higher than those of controls (p < 0.001). Coronary surgery has had a positive impact on the endothelium in the patients, prompting a decrease in signs of endothelial dysfunction and a considerable improvement in the endothelial repair mechanisms involved in angiogenesis, playing an important role in the inflammatory response and the remodelling process of ischemic myocardium in postoperative period.

Entities:  

Keywords:  Biomarkers; Circulating microparticles; Coronary artery disease; Endothelial progenitor cells

Mesh:

Substances:

Year:  2017        PMID: 28623398     DOI: 10.1007/s00380-017-1006-3

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  44 in total

Review 1.  Endothelial progenitor cells: mobilization, differentiation, and homing.

Authors:  Mihail Hristov; Wolfgang Erl; Peter C Weber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-04-24       Impact factor: 8.311

Review 2.  Microparticles as mediators of cellular cross-talk in inflammatory disease.

Authors:  Jörg H W Distler; Lars C Huber; Steffen Gay; Oliver Distler; David S Pisetsky
Journal:  Autoimmunity       Date:  2006-12       Impact factor: 2.815

Review 3.  Microvesicles from platelets: novel drivers of vascular inflammation.

Authors:  T Vajen; S F Mause; R R Koenen
Journal:  Thromb Haemost       Date:  2015-05-21       Impact factor: 5.249

Review 4.  Endothelial Progenitor Cells and In-stent Restenosis.

Authors:  Bu-Yun Xu; Mei-Xiang Xiang; Jian-an Wang
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

5.  Circulating apoptotic endothelial cells and apoptotic endothelial microparticles independently predict the presence of cardiac allograft vasculopathy.

Authors:  Neha Singh; Eline Van Craeyveld; Marc Tjwa; Agnieszka Ciarka; Jan Emmerechts; Walter Droogne; Stephanie C Gordts; Vincent Carlier; Frank Jacobs; Steffen Fieuws; Johan Vanhaecke; Johan Van Cleemput; Bart De Geest
Journal:  J Am Coll Cardiol       Date:  2012-07-24       Impact factor: 24.094

6.  Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.

Authors:  M Vasa; S Fichtlscherer; K Adler; A Aicher; H Martin; A M Zeiher; S Dimmeler
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

7.  Endothelial microparticles mediate inflammation-induced vascular calcification.

Authors:  Paula Buendía; Addy Montes de Oca; Juan Antonio Madueño; Ana Merino; Alejandro Martín-Malo; Pedro Aljama; Rafael Ramírez; Mariano Rodríguez; Julia Carracedo
Journal:  FASEB J       Date:  2014-10-23       Impact factor: 5.191

8.  Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease.

Authors:  Nikos Werner; Sven Wassmann; Patrick Ahlers; Sonja Kosiol; Georg Nickenig
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-10-20       Impact factor: 8.311

9.  Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling.

Authors:  Alexandra Aicher; Winfried Brenner; Maaz Zuhayra; Cornel Badorff; Schirin Massoudi; Birgit Assmus; Thomas Eckey; Eberhard Henze; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

10.  Microparticles in patients undergoing transcatheter aortic valve implantation (TAVI).

Authors:  Christian Jung; Michael Lichtenauer; Hans-Reiner Figulla; Bernhard Wernly; Bjoern Goebel; Martin Foerster; Christoph Edlinger; Alexander Lauten
Journal:  Heart Vessels       Date:  2016-08-03       Impact factor: 2.037

View more
  2 in total

1.  Lytic cycle of Besnoitia besnoiti tachyzoites displays similar features in primary bovine endothelial cells and fibroblasts.

Authors:  Alejandro Jiménez-Meléndez; María Fernández-Álvarez; Alexandra Calle; Miguel Ángel Ramírez; Carlos Diezma-Díaz; Patricia Vázquez-Arbaizar; Luis Miguel Ortega-Mora; Gema Álvarez-García
Journal:  Parasit Vectors       Date:  2019-11-04       Impact factor: 3.876

Review 2.  Common Injuries and Repair Mechanisms in the Endothelial Lining.

Authors:  Ling-Bing Meng; Kun Chen; Yuan-Meng Zhang; Tao Gong
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.